Literature DB >> 17333517

Lunar phases and zodiac signs do not influence quality of radical cystectomy--a statistical analysis of 452 patients with invasive bladder cancer.

Matthias May1, Kay-Patrick Braun, Christian Helke, Willi Richter, Horst Vogler, Bernd Hoschke, Michael Siegsmund.   

Abstract

OBJECTIVE: To determine the influence of the lunar phases and the position of the moon in the zodiac on the frequency of complications and the survival of bladder cancer patients after radical cystectomy. It has been postulated that radical cystectomy performed during the waxing moon, or particularly at full moon, or at the zodiac sign Libra is associated with a poorer outcome.
MATERIAL AND METHODS: We tested this hypothesis by evaluating the progression-free survival, the complication rate and the re-operation rate for 452 consecutive patients after radical cystectomy. In this retrospective review, the dates of surgery were allocated to the lunar phases and the zodiac signs. Based on these classifications, the patients were placed in groups which combined the lunar phase laws and differentiated between evidently unfavorable (full moon or waxing moon and/or the zodiac sign Libra; assigned to group 1) and favorable periods for surgery (new moon or waning moon and other signs of the zodiac apart from Libra; assigned to group 2). The mean follow-up was 49 months (range 0-158 months).
RESULTS: A total of 244 patients (54%) were operated during an unfavorable period (group 1) and 208 (46%) patients during the auspicious period (group 2). The mean age, gender and kind of urinary derivation did not differ significantly in the two groups. Pathological tumor stages were evenly distributed according to the lunar phase groups (P = 0.713). We found no significant differences in the perioperative mortality rates, early re-operation rates, early complications, and late complications across the two groups. No significant differences in progression-free survival were observed when timing of cystectomy during the lunar cycle was considered (P = 0.231).
CONCLUSIONS: Our analysis demonstrated no predictable influence of the lunar phase on survival or complications. Although this was not a prospective randomized trial, the statistical magnitude of the results do not support any recommendations for scheduling patients for radical cystectomy at any particular day of the lunar phase.

Entities:  

Mesh:

Year:  2007        PMID: 17333517     DOI: 10.1007/s11255-006-9165-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  Circadian rhythm of cytokine secretion following thermal injury in mice: implications for burn and trauma research.

Authors:  Rene G Holzheimer; Paul Curley; Inna B Saporoschetz; Jane M Doherty; John A Mannick; Mary L Rodrick
Journal:  Shock       Date:  2002-06       Impact factor: 3.454

Review 2.  Suicide and lunar cycles: a critical review over 28 years.

Authors:  S J Martin; I W Kelly; D H Saklofske
Journal:  Psychol Rep       Date:  1992-12

3.  Moon talk: the cyclic periodicity of postoperative hemorrhage.

Authors:  E J ANDREWS
Journal:  J Fla Med Assoc       Date:  1960-05

4.  The effect of the lunar cycle on frequency of births and birth complications.

Authors:  Jill M Arliss; Erin N Kaplan; Shelley L Galvin
Journal:  Am J Obstet Gynecol       Date:  2005-05       Impact factor: 8.661

5.  Human births and the phase of the moon.

Authors:  G O Abell; B Greenspan
Journal:  N Engl J Med       Date:  1979-01-11       Impact factor: 91.245

6.  Lunar phases and survival of breast cancer patients--a statistical analysis of 3,757 cases.

Authors:  C Peters-Engl; W Frank; F Kerschbaum; U Denison; M Medl; P Sevelda
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

7.  Effect of lunar cycle on temporal variation in cardiopulmonary arrest in seven emergency departments during 11 years.

Authors:  Donald W Alves; John R Allegra; Dennis G Cochrane; Greg Cable
Journal:  Eur J Emerg Med       Date:  2003-09       Impact factor: 2.799

8.  A double-blind, controlled clinical trial of homeopathy and an analysis of lunar phases and postoperative outcome.

Authors:  J Smolle; G Prause; H Kerl
Journal:  Arch Dermatol       Date:  1998-11

9.  Lunar phase does not influence surgical quality.

Authors:  René Gordon Holzheimer; C Nitz; U Gresser
Journal:  Eur J Med Res       Date:  2003-09-29       Impact factor: 2.175

10.  Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.

Authors:  M May; T Nitzke; C Helke; H Vogler; B Hoschke
Journal:  Scand J Urol Nephrol       Date:  2004
View more
  5 in total

1.  Howling at the moon? The effect of lunar phases on post-surgical pain outcome.

Authors:  Marcus Komann; Claudia Weinmann; Winfried Meissner
Journal:  Br J Pain       Date:  2014-05

2.  Popular belief meets surgical reality: impact of lunar phases, Friday the 13th and zodiac signs on emergency operations and intraoperative blood loss.

Authors:  Jochen Schuld; Jan E Slotta; Simone Schuld; Otto Kollmar; Martin K Schilling; Sven Richter
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

3.  Lunar cycle may have an effect on Shock Wave Lithotripsy related pain outcome.

Authors:  Hüsnü Tokgöz; Soner Yalçınkaya; Ekrem İslamoğlu; Kaan Karamık; Özlem Tokgöz; Murat Savaş
Journal:  Ghana Med J       Date:  2017-12

4.  The Influence of Lunar Phases on Complications in Cataract Surgery: An Analysis of 16,965 Patients.

Authors:  Eva-Maria Faschinger; Pia Veronika Vécsei-Marlovits; Dieter Franz Rabensteiner; Birgit Weingessel
Journal:  J Ophthalmol       Date:  2017-07-16       Impact factor: 1.909

5.  Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation.

Authors:  A Kleespies; M Mikhailov; P N Khalil; S Pratschke; A Khandoga; M Stangl; W D Illner; M K Angele; K W Jauch; M Guba; J Werner; M Rentsch
Journal:  BMC Complement Altern Med       Date:  2017-09-04       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.